文献速递肿瘤 PET/CT

多发性骨髓瘤患者以18F-FDG摄取增高为唯一表现继发胃肠道淀粉样变性

Secondary Gastrointestinal Amyloidosis With Increased 18 F-FDG Uptake as the Only Presentation in a Patient With Multiple Myeloma.
PubMed 文献 · Clin Nucl Med · 2022-02-21

一名63岁女性因腹痛和便血为排查潜在恶性肿瘤接受18F-FDG PET/CT,PET/CT检出肠壁弥漫性增厚伴结肠内放射性浓聚。患者随后被诊断为多发性骨髓瘤和继发性胃肠道淀粉样变性,经9个周期化疗后骨髓瘤和淀粉样变性均达完全缓解。该病例提示淀粉样变性所致胃肠道异常可能是多发性骨髓瘤患者18F-FDG PET/CT上唯一的表现和发现。

要点

  • 多发性骨髓瘤患者可仅以胃肠道淀粉样变性的18F-FDG PET/CT异常为表现。
  • PET/CT检出肠壁弥漫性增厚伴结肠内放射性浓聚。
  • 经9个周期化疗后骨髓瘤和淀粉样变性均达完全缓解。

核心结论

  • 淀粉样变性所致胃肠道异常可能是多发性骨髓瘤患者18F-FDG PET/CT上唯一的表现和发现。

研究设计与样本

  • 病例报告:一名63岁女性因腹痛和便血为排查潜在恶性肿瘤转诊行18F-FDG PET/CT。

主要发现

  • PET/CT检出肠壁弥漫性增厚伴结肠内放射性浓聚。
  • 患者随后被诊断为多发性骨髓瘤和继发性胃肠道淀粉样变性。
  • 经9个周期化疗后骨髓瘤和淀粉样变性均达完全缓解。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A 63-year-old woman presented with abdominal pain and hematochezia was referred for 18 F-FDG PET/CT for the underlying malignancy. PET/CT detected diffuse thickening of the bowel walls with intense radioactivity in the colons. She was later diagnosed with multiple myeloma and secondary gastrointestinal amyloidosis, and achieved complete response of myeloma and amyloidosis after 9 cycles of chemotherapy. This case highlighted that gastrointestinal abnormality caused by amyloidosis might be the only presenting symptoms and findings in 18 F-FDG PET/CT in patients with multiple myeloma.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Ding J, Huo L, Cui R, et al. Secondary Gastrointestinal Amyloidosis With Increased 18 F-FDG Uptake as the Only Presentation in a Patient With Multiple Myeloma. Clin Nucl Med. 2022. PMID: 35195581. doi:10.1097/RLU.0000000000004092

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。